UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2016-05, Vol.150 (5), p.1160-1170.e3

2016

Volltextzugriff (PDF)

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Cochrane database of systematic reviews, 2018-10, Vol.10 (10), p.CD011510

2018

Volltextzugriff (PDF)

Somatostatin analogues for acute bleeding oesophageal varices

Cochrane database of systematic reviews, 2008-07 (3), p.CD000193

2008

Volltextzugriff (PDF)

Beta-blockers in the era of precision medicine in patients with cirrhosis

Journal of hepatology, 2023-04, Vol.78 (4), p.866-872

2023

Volltextzugriff (PDF)

Beta adrenergic blockade and decompensated cirrhosis

Journal of hepatology, 2017-04, Vol.66 (4), p.849-859

2017

Volltextzugriff (PDF)

AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review

Gastroenterology, 2024-01, Vol.166 (1), p.202-210

2024

Volltextzugriff (PDF)

Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults

Cochrane database of systematic reviews, 2012-08, Vol.2012 (8), p.CD004544

2012

Volltextzugriff (PDF)

Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.954-963

2014

Volltextzugriff (PDF)

Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis: A randomized controlled trial

Hepatology (Baltimore, Md.), 2024-08, Vol.80 (2), p.376-388

2024

Volltextzugriff (PDF)

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Clinical and Molecular Hepatology, 2020, 26(2), , pp.83-127

2020

Volltextzugriff (PDF)

Comparison of 1‐day versus 3‐day intravenous terlipressin in cirrhosis patients with variceal bleeding: A pilot randomised controlled trial

Alimentary pharmacology & therapeutics, 2024-03, Vol.59 (5), p.645-655

2024

Volltextzugriff (PDF)

Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis

Alimentary pharmacology & therapeutics, 2023-03, Vol.57 (5), p.454-463

2023

Volltextzugriff (PDF)

A Randomized Controlled Trial of Propranolol Use During Ligation Program for Secondary Prophylaxis of Esophageal Variceal Bleeding

The American journal of gastroenterology, 2024-02, Vol.119 (2), p.278-286

2024

Volltextzugriff (PDF)

The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study

Journal of hepatology, 2015-11, Vol.63 (5), p.1118-1125

2015

Volltextzugriff (PDF)

Management of Gastric Varices

Clinical gastroenterology and hepatology, 2014-06, Vol.12 (6), p.919-928.e1

2014

Volltextzugriff (PDF)

Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first‐line therapies

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1458-1471

2018

Volltextzugriff (PDF)

Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (S1), p.11-26

Bajaj, J. S.

2016

Volltextzugriff (PDF)

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list

Alimentary pharmacology & therapeutics, 2019-08, Vol.50 (4), p.435-441

2019

Volltextzugriff (PDF)

Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis

Cochrane database of systematic reviews, 2019-09, Vol.9 (2), p.CD010546

2019

Volltextzugriff (PDF)

Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study

Alimentary pharmacology & therapeutics, 2021-02, Vol.53 (4), p.531-539

2021

Volltextzugriff (PDF)

Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices

Journal of hepatology, 2023-07, Vol.79 (1), p.e21-e23

2023

Volltextzugriff (PDF)

Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis

PloS one, 2024-06, Vol.19 (6), p.e0302811

2024

Volltextzugriff (PDF)

Letter: non‐selective beta‐blockers in cirrhosis‐effect beyond portal hypertension

Alimentary pharmacology & therapeutics, 2022-07, Vol.56 (1), p.184-185

2022

Volltextzugriff (PDF)

Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial

The American journal of gastroenterology, 2020-05, Vol.115 (5), p.729-737

2020

Volltextzugriff (PDF)

Current and future pharmacological therapies for managing cirrhosis and its complications

World journal of gastroenterology : WJG, 2019-02, Vol.25 (8), p.888-908

2019

Volltextzugriff (PDF)

1 – 25 von 1.829

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.505)
Mit Volltextzugriff
(1.055)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.788)
Science & Technology
(1.164)
Life Sciences & Biomedicine
(1.155)
Male
(895)
Esophageal And Gastric Varices - Drug Therapy
(844)
Female
(804)
Middle Aged
(794)
Gastroenterology & Hepatology
(762)
Gastrointestinal Hemorrhage - Drug Therapy
(680)
Gastrointestinal Hemorrhage - Etiology
(589)
Esophageal And Gastric Varices - Complications
(552)
Adult
(541)
Liver Cirrhosis - Complications
(508)
Aged
(478)
Biological And Medical Sciences
(477)
Medical Sciences
(475)
Esophageal And Gastric Varices - Therapy
(472)
Esophageal And Gastric Varices - Etiology
(424)
Gastrointestinal Hemorrhage - Therapy
(327)
Gastrointestinal Hemorrhage - Prevention & Control
(314)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(89)
The American Journal Of Gastroenterology
(75)
Gastroenterology
(66)
Gastrointestinal Endoscopy
(53)
Journal Of Hepatology
(53)
Endoscopy
(45)
Alimentary Pharmacology & Therapeutics
(40)
The Lancet
(34)
Scandinavian Journal Of Gastroenterology
(31)
Hepato-Gastroenterology
(30)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Somatostatin analogues for acute bleeding oesophageal varices

Beta-blockers in the era of precision medicine in patients with cirrhosis

Beta adrenergic blockade and decompensated cirrhosis

AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review

Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults

Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage

Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis: A randomized controlled trial

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Comparison of 1‐day versus 3‐day intravenous terlipressin in cirrhosis patients with variceal bleeding: A pilot randomised controlled trial

Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis

A Randomized Controlled Trial of Propranolol Use During Ligation Program for Secondary Prophylaxis of Esophageal Variceal Bleeding

The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study

Management of Gastric Varices

Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first‐line therapies

Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list

Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis

Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study

Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices

Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis

Letter: non‐selective beta‐blockers in cirrhosis‐effect beyond portal hypertension

Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial

Current and future pharmacological therapies for managing cirrhosis and its complications

Suchergebnisse filtern